CCI4EU - Cost of health care and drugs
MATERIALS AVAILABLE
CCI4EU - Cost of health care and drugs
MATERIALS AVAILABLE
Chairs: Mark Lawler, UK & Wim van Harten, NL
Introduction
CCI4EU (Comprehensive Cancer Infrastructures for the European Union) is a European project aiming to help Member States and Associated Countries improve or develop their existing or future Comprehensive Cancer Infrastructures (CCIs), by helping develop their research & innovation-related capacities.
This course is the fourth of 10 online training courses organised within the project to help countries develop an effective comprehensive infrastructure and widen the reach of this grant. The topic of this online course is: Cost of health care and drugs.
The aim is discuss the economic burden and the economic dividends of cancer.
Target audience
Directors, managers and coordinators at hospitals/clinics/CCIs, clinicians, researchers, patients advocates.
Course delivery
The first part of this course was made available on this website from 3 February 2025.
The second part of this online course was held live on 28 February 2025 via this webpage. The entire course was recorded and is now available as on-demand material.
To access the on-demand materials (after the live streaming), participants must register to the course, login to the e-ESO platform and click on the play buttons inside the course programme. Official language
The course was held in English. Translations are not provided, but English subtitles can be activated and transcriptions can be automatically translated using free online tools.
Registration
Registration to the course is free but mandatory.
Certificate of attendance
Participants will be issued a certificate of attendance once they have completed a minimum attendance of 75% of the entire course. An online evaluation questionnaire must be completed in order to receive the certificate that will be issued by email. The evaluation questionnaire will appear in the right-hand column of the course page when participants have completed 75% of the course.
Organising secretariat
Sarah Jennie Goldman: sgoldman@eso.net
Francesca Marangoni: fmarangoni@eso.net
Sonia Bulgarelli: sbulgarelli@eso.net
03/02/2025
Introduction to the pre-recorded part of the course
03/02/2025
Cost of drugs and negotiation with pharma
The economic burden of cancer
Mark Lawler (UK)Cost of Cancers (UK)
Katie Spencer (UK)Cost of Cancer Medicines across EU
Nora Franzen (NL)Health Technology Assessment alongside the translation research process (VR)
Valesca Retel (NL)How can we measure the clinical performance and value of drugs after adoption?
Peter S Hall (UK)03/02/2025
Financial toxicity
Financial toxicity (use of measurement instruments)
Rachel Eckford (DE)Socio-economic outcomes of Adolecent and Young Adult (AYA) cancer patients
Silvie Janssen (NL)03/02/2025
The cost of diagnostics
Costs, budget impact and/or cost effectiveness of sequencing
Astrid Kramer (NL)Cost of testing vs cost of not testing
Peter Keeling (UK)Health economics and diagnostics/precision medicine
Raymond Henderson (UK)Costs and cost effectiveness of early detection in head and neck cancer
Lionel Perrier (FR)03/02/2025
Regulatory part
How countries decide via agencies on coverage
Martina Garau (UK)How innovation gets to the patients
Wim H. Van Harten (NL)Coverage with evidence development programs
Joost Verbeek (NL)28/02/2025
LIVE STREAMING
28/02/2025
Introduction & Welcome to the live course
28/02/2025
Live Presentations & Discussions (part 1)
Comparative overview of costs and infrastructure for cancer treatement in (especially EU) OECD countries
Caroline Berchet (FR)Value based health care and use of PROMs in the clinic
Rita Silva Calisto (PT)Financial Sustainability
Ajay Aggarwal (UK)Discussion
28/02/2025
Live Presentations & Discussions (part 2)
Financial Toxicity: Socio-economic impact
Wim H. Van Harten (NL)Personal Story Advocate
Marianne Massart (LU)Right to be Forgotten
Mark Lawler (UK) Francoise Meunier (BE)Discussion
28/02/2025
Live Cases & Discussions
Deploying data to influence cancer policy
Mark Lawler (UK)Roundtable and Discussion
Diagnostics case
Valesca Retel (NL)Roundtable and discussion
28/02/2025
Take home message and closing remarks
28/02/2025
End of the course
Ajay Aggarwal
London School of Hygiene and Tropical Medicine, Department of Health Services Research and Policy, London, UK
Astrid Kramer
, , ,
Caroline Berchet
Organization for Economic Co-operation and Development (OECD), Healh Policy, Paris Cedex 16, FR
Francoise Meunier
1050 brussels, BE
Joost Verbeek
, , ,
Katie Spencer
, , ,
Lionel Perrier
, , ,
Marianne Massart
, , ,
Mark Lawler
Queens University Hospital, Centre for Cancer Research and Cell Biology, Belfast, UK
Martina Garau
, , ,
Nora Franzen
, , ,
Peter Keeling
, , ,
Peter S Hall
, , ,
Rachel Eckford
German Cancer Research Center (DKFZ), Foundation under Public Law, Heidelberg, DE
Raymond Henderson
, , ,
Rita Silva Calisto
Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E., ORLab, Porto, PT
Silvie Janssen
, , ,
Valesca Retel
, , ,
Wim H. Van Harten
Rijnstate Ziekenhuis, Chairman Board of Directors, Arnhem, NL
This course is part of:
Funded by:
Funded by:
